Challenging times. Susan dr. Azra raza, you have a new book out called the new cell. What is the message . Dr. Raza the message is Early Detection and prevention of cancer way before it becomes the monstrosity that has been a stigma for centuries. Susan if you had a goal with this book, what would that goal be . Dr. Raza to bring the patient back front and center into every conversation about cancer. To look at everything we are doing in the cancer paradigm through the prism of human anguish. And let everyone see what are the human costs of pursuing cancers to the last. Susan your book readers will find an interesting mix. It has poetry, patients stories and a lot of technical and clinical analysis in it. What were you thinking . Who is your intended audience . Dr. Raza it was not so much the audience but the way i was trying to tell the story. First, i was only going to write about my patients with nothing personal but once i told the stories in deep, granular detail, i felt dishonest
Trump today on the flip side, president Obama Holding two events in florida, including one a short time from now. You have senator Bernie Sanders appearing with Hillary Clinton in North Carolina to want. We havent seen the two of them together i think since he endorsed her some time ago back in new hampshire. But back to these live pictures. This is the philadelphia suburb of berwyn, pennsylvania. She will be giving a speech any moment where, by the way, weve just learned, the clintons and obamas will be appear together not in berwyn but in downtown philadelphia next monday night on the eve of election day. So lets start where were looking here in the suburbs with sara murray standing by ahead of Melania Trumps speech. Lets rip the bandaid off. We remember that rnc speech. We remember how it was wonderful and then we remember how the world learned she borrowed words from the first lady. Can we what do you know as far as how shes been preparing for this one, sara . Thant was a very disa
02.05.2024 - KT-474/SAR444656 (IRAK4) Phase 2 clinical trials ongoing in HS and ADÂ with data expected in the first half of 2025 KT-621 (STAT6) expected to start Phase 1 in the second half of 2024 and KT-294 (TYK2) expected to start Phase 1 in the first half of .